Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Tucker, Thomas"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 422
Tytuł:
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors.
Autorzy:
Tucker, Thomas J.
Embrey, Mark W.
Alleyne, Candice
Amin, Rupesh P.
Bass, Alan
Bhatt, Bhavana
Bianchi, Elisabetta
Branca, Danila
Bueters, Tjerk
Buist, Nicole
Ha, Sookhee N.
Hafey, Mike
Huaibing He
Higgins, John
Johns, Douglas G.
Kerekes, Angela D.
Koeplinger, Kenneth A.
Kuethe, Jeffrey T.
Nianyu Li
Murphy, BethAnn
Pokaż więcej
Źródło:
Journal of Medicinal Chemistry; 11/25/2021, Vol. 64 Issue 22, p16770-16800, 31p
Czasopismo naukowe
Szczegóły
Tytuł:
Prevalence of human papillomavirus genotypes in high‐grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
Autorzy:
Mix, Jacqueline M. (AUTHOR)
Saraiya, Mona (AUTHOR)
Thompson, Trevor D. (AUTHOR)
Querec, Troy D. (AUTHOR)
Greek, April (AUTHOR)
Tucker, Thomas C. (AUTHOR)
Peters, Edward S. (AUTHOR)
Lynch, Charles F. (AUTHOR)
Hernandez, Brenda Y. (AUTHOR)
Copeland, Glenn (AUTHOR)
Goodman, Marc T. (AUTHOR)
Unger, Elizabeth R. (AUTHOR)
Pokaż więcej
Źródło:
Cancer (0008543X). Oct2021, Vol. 127 Issue 19, p3614-3621. 8p.
Czasopismo naukowe
Szczegóły
Tytuł:
Pathology Laboratory Policies and Procedures for Releasing Diagnostic Tissue for Cancer Research.
Autorzy:
Yuan Y; The Surveillance Research Program, Division of Cancer Control and Population Sciences (Yuan, Van Dyke, Petkov, Hussey, Penberthy), National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Van Dyke AL; The Surveillance Research Program, Division of Cancer Control and Population Sciences (Yuan, Van Dyke, Petkov, Hussey, Penberthy), National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Petkov VI; The Surveillance Research Program, Division of Cancer Control and Population Sciences (Yuan, Van Dyke, Petkov, Hussey, Penberthy), National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Hussey S; The Surveillance Research Program, Division of Cancer Control and Population Sciences (Yuan, Van Dyke, Petkov, Hussey, Penberthy), National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Moravec R; The Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis (Moravec), National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Altekruse SF; The HIV/AIDS Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland (Altekruse).
Sandoval M; The Cancer Registry of Greater California, Department of Public Health, Sacramento (Sandoval, Cress).
Cress RD; The Cancer Registry of Greater California, Department of Public Health, Sacramento (Sandoval, Cress).
Mueller LM; The Connecticut Tumor Registry, State Department of Public Health, Hartford (Mueller).
Mogi A; The Hawaii Tumor Registry, University of Hawaii Cancer Center, Honolulu (Mogi, Hernandez).
Hernandez BY; The Hawaii Tumor Registry, University of Hawaii Cancer Center, Honolulu (Mogi, Hernandez).
Selk FR; The Iowa Cancer Registry, The University of Iowa, Iowa City (Selk, Lynch).
Lynch CF; The Iowa Cancer Registry, The University of Iowa, Iowa City (Selk, Lynch).
Tucker TC; The Kentucky Cancer Registry, University of Kentucky, Markey Cancer Center, Lexington (Tucker).
Lynch MA; The Louisiana Tumor Registry, Louisiana State University School of Public Health, New Orleans (Lynch, Lefante, Wu).
Lefante C; The Louisiana Tumor Registry, Louisiana State University School of Public Health, New Orleans (Lynch, Lefante, Wu).
Wu XC; The Louisiana Tumor Registry, Louisiana State University School of Public Health, New Orleans (Lynch, Lefante, Wu).
Sweeney C; The Utah Cancer Registry (Sweeney, Doherty).
Doherty JA; The Utah Cancer Registry (Sweeney, Doherty).; Huntsman Cancer Institute (Doherty), University of Utah, Salt Lake City.
Penberthy LS; The Surveillance Research Program, Division of Cancer Control and Population Sciences (Yuan, Van Dyke, Petkov, Hussey, Penberthy), National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Feb 01; Vol. 145 (2), pp. 222-226.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Policy*
Laboratories/*legislation & jurisprudence
Neoplasms/*pathology
Research/*legislation & jurisprudence
SEER Program/*legislation & jurisprudence
Formaldehyde ; Humans ; Neoplasms/diagnosis ; Paraffin Embedding ; Pathology ; Tissue Fixation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky.
Autorzy:
Larson KL; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.
Huang B; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.; Division of Cancer Biostatistics, University of Kentucky, Lexington, Kentucky, United States of America.; Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, United States of America.
Chen Q; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.
Tucker T; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.; Department of Epidemiology, University of Kentucky, Lexington, Kentucky, United States of America.
Schuh M; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.
Arnold SM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.; Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, United States of America.
Kolesar JM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.; Department of Pharmacy Practice and Science, University of Kentucky, Lexington, Kentucky, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Aug 18; Vol. 15 (8), pp. e0237790. Date of Electronic Publication: 2020 Aug 18 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*drug therapy
Erlotinib Hydrochloride/*therapeutic use
Genetic Testing/*statistics & numerical data
Lung Neoplasms/*drug therapy
Administrative Claims, Healthcare/statistics & numerical data ; Adult ; Age Factors ; Aged ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; DNA Mutational Analysis/economics ; DNA Mutational Analysis/statistics & numerical data ; Drug Prescriptions/economics ; Drug Prescriptions/statistics & numerical data ; Drug Utilization/economics ; Drug Utilization/statistics & numerical data ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Female ; Genetic Testing/economics ; Healthcare Disparities/economics ; Humans ; Kentucky/epidemiology ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Male ; Medicaid/economics ; Medicaid/statistics & numerical data ; Medicare/economics ; Medicare/statistics & numerical data ; Middle Aged ; Mutation ; Poverty/statistics & numerical data ; Precision Medicine/economics ; Precision Medicine/statistics & numerical data ; Registries/statistics & numerical data ; Retrospective Studies ; Sex Factors ; Survival Analysis ; United States ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 422

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies